Preliminary results from a randomized and prospective study of high-dose immunoglobulin versus monoclonal antibody in the rescue of steroid-resistant rejections.
Instituto de Nefrologia, Buenos Aires, Argentina.
D
D
Casadei
M
M
Rial
J
J
Argento
J
J
Goldberg
E
E
Raimondi
D001707:Biopsy, Needle; D017252:CD3 Complex / Q000276:immunology; D003404:Creatinine / Q000097:blood; D004351:Drug Resistance; D006084:Graft Rejection / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D018655:Lymphocyte Count; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D011446:Prospective Studies; D013601:T-Lymphocytes / Q000276:immunology
D017252:CD3 Complex; D016756:Immunoglobulins, Intravenous; D016853:Muromonab-CD3; D003404:Creatinine